Login / Signup
All Bruton's tyrosine kinase inhibitors have similar efficacy and risks: Yes.
Carlos Navas
Published in:
Multiple sclerosis (Houndmills, Basingstoke, England) (2022)
Keyphrases
</>
human health
chronic myeloid leukemia
risk assessment
climate change